Pacala Mark L bought TOI

November 20, 2025 · Form 4 insider transaction

Pacala Mark L bought 46,296 shares of Starling Oncology Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
46,296
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateNovember 20, 2025
Filing dateNovember 24, 2025
Shares owned after221,267
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date.

View the original Form 4 on SEC EDGAR